Pritelivir

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

The US FDA has approved Asahi Kasei's new drug HOVILPRI for persistent herpes infections in immunocompromised adults.

8 sources 8 articles v 6 10h ago

\n \n \n

\n \n \n \n